Articles with public access mandates - Jonathan ChouLearn more
Not available anywhere: 3
Transcription-associated cyclin-dependent kinases as targets and biomarkers for cancer therapy
J Chou, DA Quigley, TM Robinson, FY Feng, A Ashworth
Cancer discovery 10 (3), 351-370, 2020
Mandates: US National Institutes of Health
Prostate-specific membrane antigen and fluciclovine transporter genes are associated with variable clinical features and molecular subtypes of primary prostate cancer
CE Chu, M Alshalalfa, M Sjöström, SG Zhao, Y Liu, J Chou, A Herlemann, ...
European urology 79 (6), 717-721, 2021
Mandates: US National Institutes of Health, Swedish Research Council
PD54-02 CHARACTERIZATION OF PSMA AND 18F-FLUCICLOVINE TRANSPORTER GENE EXPRESSION IN LOCALIZED PROSTATE CANCER
C Chu, M Alshalalfa, M Sjostrom, S Zhao, A Herlemann, J Chou, B Mahal, ...
Journal of Urology 203, e1103-e1104, 2020
Mandates: US National Institutes of Health
Available somewhere: 37
Remodelling the extracellular matrix in development and disease
C Bonnans, J Chou, Z Werb
Nature reviews Molecular cell biology 15 (12), 786-801, 2014
Mandates: US National Institutes of Health, National Institute of Health and Medical …
Genomic hallmarks and structural variation in metastatic prostate cancer
DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ...
Cell 174 (3), 758-769. e9, 2018
Mandates: US Department of Defense, US National Institutes of Health, Howard Hughes …
Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer
YM Wu, M Cieślik, RJ Lonigro, P Vats, MA Reimers, X Cao, Y Ning, ...
Cell 173 (7), 1770-1782. e14, 2018
Mandates: US Department of Defense, US National Institutes of Health, Howard Hughes …
GATA3 suppresses metastasis and modulates the tumour microenvironment by regulating microRNA-29b expression
J Chou, JH Lin, A Brenot, J Kim, S Provot, Z Werb
Nature cell biology 15 (2), 201-213, 2013
Mandates: US National Institutes of Health
GATA3 in development and cancer differentiation: cells GATA have it!
J Chou, S Provot, Z Werb
Journal of cellular physiology 222 (1), 42-49, 2010
Mandates: US National Institutes of Health
The DNA methylation landscape of advanced prostate cancer
SG Zhao, WS Chen, H Li, A Foye, M Zhang, M Sjöström, R Aggarwal, ...
Nature genetics 52 (8), 778-789, 2020
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Swedish …
microRNA-mediated regulation of the tumor microenvironment
J Chou, P Shahi, Z Werb
Cell cycle 12 (20), 3262-3271, 2013
Mandates: US National Institutes of Health
Zeppo1 is a novel metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization
EM Slorach, J Chou, Z Werb
Genes & development 25 (5), 471-484, 2011
Mandates: US National Institutes of Health
Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin
CE Chu, M Sjöström, EA Egusa, EA Gibb, ML Badura, J Zhu, VS Koshkin, ...
Clinical Cancer Research 27 (18), 5123-5130, 2021
Mandates: US National Institutes of Health, Swedish Research Council
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy
M Owyong, J Chou, RJE van den Bijgaart, N Kong, G Efe, C Maynard, ...
Life science alliance 2 (6), 2019
Mandates: US National Science Foundation, US Department of Defense, US National …
Clinical outcomes in cyclin-dependent kinase 12 mutant advanced prostate cancer
MA Reimers, SM Yip, L Zhang, M Cieslik, M Dhawan, B Montgomery, ...
European urology 77 (3), 333-341, 2020
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice
CS Devignes, Y Aslan, A Brenot, A Devillers, K Schepers, S Fabre, ...
Proceedings of the National Academy of Sciences 115 (5), E992-E1001, 2018
Mandates: US National Institutes of Health, National Institute of Health and Medical …
The transcription factor ZNF217 is a prognostic biomarker and therapeutic target during breast cancer progression
LE Littlepage, AS Adler, H Kouros-Mehr, G Huang, J Chou, SR Krig, ...
Cancer discovery 2 (7), 638-651, 2012
Mandates: US National Institutes of Health, Canadian Institutes of Health Research
TROP2 expression across molecular subtypes of urothelial carcinoma and enfortumab vedotin-resistant cells
J Chou, K Trepka, M Sjöström, EA Egusa, CE Chu, J Zhu, E Chan, ...
European urology oncology 5 (6), 714-718, 2022
Mandates: US National Institutes of Health, Swedish Research Council
GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis
P Shahi, CY Wang, J Chou, C Hagerling, H Gonzalez Velozo, ...
Oncogene 36 (40), 5567-5575, 2017
Mandates: US National Institutes of Health
MicroRNAs play a big role in regulating ovarian cancer–associated fibroblasts and the tumor microenvironment
J Chou, Z Werb
Cancer discovery 2 (12), 1078-1080, 2012
Mandates: US National Institutes of Health
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study
VS Koshkin, N Henderson, M James, D Natesan, D Freeman, A Nizam, ...
Cancer 128 (6), 1194-1205, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program